Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-28

FDA Approved: BUSPIRONE HCL — Supplemental Application (Advagen Pharma Ltd)

View source ↗

Summary

The FDA approved a supplemental application for Buspirone hydrochloride (Buspirone HCl) filed by Advagen Pharma Ltd under ANDA075521, adding a generic version t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone HCl (Buspirone hydrochloride)

Snippet

SUPPL AP for BUSPIRONE HCL (BUSPIRONE HYDROCHLORIDE)